Toulouse, France, September 21st of 2023 Cell-Easy, a specialized contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre as the Chief Scientific Officer.   Over the years, Cell-Easy has recognized the challenges faced by biotechs in bridging the gap between early-stage projects